Capricor Therapeutics Depreciation & Amortization 2011-2026 | CAPR

Annual Depreciation & Amortization Capricor Therapeutics

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
1.07 M	533 K	246 K	144 K	172 K	158 K	144 K	126 K	111 K	41.9 K	26.9 K	20.3 K	7.51 K

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
1.07 M	7.51 K	215 K

Quarterly Depreciation & Amortization Capricor Therapeutics

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
495 K	486 K	405 K	-	361 K	357 K	331 K	-	276 K	255 K	230 K	-	137 K	112 K	92.5 K	-	167 K	102 K	50.1 K	-	102 K	65.6 K	33 K	-	129 K	86.4 K	43.3 K	-	114 K	73 K	34.1 K	-	110 K	76.1 K	38.8 K	-	91.8 K	65.1 K	31.6 K	-	79.8 K	51 K	24.8 K	-	28.4 K	16.2 K	6.46 K	-	20.4 K	13.8 K	6.12 K	-	4.81 K	3.36 K	1.79 K	-	5.88 K	4.07 K	2.19 K

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
495 K	1.79 K	116 K

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
Acer Therapeutics ACER	66 K	-	2.71 %	$ 14 M	USA
I-Mab IMAB	23.9 M	-	-	$ 866 M	China
AgeX Therapeutics AGE	131 K	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	744 K	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	1.51 M	-	-	$ 26.5 M	USA
ARCA biopharma ABIO	27 K	-	1052.0 %	$ 415 M	USA
Acorda Therapeutics ACOR	31.7 M	-	-24.86 %	$ 820 K	USA
Acasti Pharma ACST	7 K	-	4.01 %	$ 150 M	Canada
Adverum Biotechnologies ADVM	3.65 M	-	-	$ 86.2 M	USA
AIkido Pharma AIKI	105 K	-	1.93 %	$ 17.4 M	USA
Akero Therapeutics AKRO	18 K	-	-	$ 3.67 B	USA
Akouos AKUS	2.49 M	-	0.23 %	$ 488 M	USA
Albireo Pharma ALBO	274 K	-	-0.23 %	$ 916 M	USA
Allena Pharmaceuticals ALNA	363 K	-	3.16 %	$ 1.9 M	USA
Aileron Therapeutics ALRN	63 K	-	10.36 %	$ 9.8 M	USA
AlloVir ALVR	398 K	-	4.14 %	$ 49.1 M	USA
Alpine Immune Sciences ALPN	597 K	-	-	$ 2.17 B	USA
Aeterna Zentaris AEZS	58 K	-	5.93 %	$ 314 M	Canada
Ampio Pharmaceuticals AMPE	122 K	-	-11.43 %	$ 502 K	USA
Applied Molecular Transport AMTI	3.13 M	-	-	$ 10.1 M	USA
Aravive ARAV	886 K	-	-13.39 %	$ 1.45 M	USA
Aptose Biosciences APTO	32 K	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	122 K	-	-39.0 %	$ 4.57 M	USA
Athira Pharma ATHA	970 K	-	-	$ 269 M	USA
Aridis Pharmaceuticals ARDS	487 K	-	17.91 %	$ 11.1 M	USA
Arena Pharmaceuticals ARNA	3.87 M	-	-6.81 %	$ 3.04 B	USA
Athersys ATHX	1.43 M	-	3.77 %	$ 22.4 M	USA
Axcella Health AXLA	412 K	-	-16.42 %	$ 249 M	USA
AVEO Pharmaceuticals AVEO	67 K	-	-	$ 521 M	USA
Atreca BCEL	5.46 M	-	-11.76 %	$ 5.79 M	USA
AVROBIO AVRO	617 K	-	1083.1 %	$ 745 M	USA
Agenus AGEN	13.6 M	$ 3.27	-1.8 %	$ 1.17 M	USA
Ayala Pharmaceuticals AYLA	162 K	-	-	$ 7.46 M	Israel
Agios Pharmaceuticals AGIO	5.2 M	$ 28.72	-5.0 %	$ 1.66 B	USA
bluebird bio BLUE	28 M	-	-	$ 546 M	USA
Brickell Biotech BBI	41 K	-	-5.38 %	$ 6.06 M	USA
Advaxis ADXS	369 K	-	-9.65 %	$ 45.9 M	USA
Baudax Bio BXRX	165 K	-	0.59 %	$ 63 K	USA
Calithera Biosciences CALA	300 K	-	-10.95 %	$ 876 K	USA